These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 36000426)

  • 1. Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension.
    Gnanenthiran SR; Borghi C; Burger D; Caramelli B; Charchar F; Chirinos JA; Cohen JB; Cremer A; Di Tanna GL; Duvignaud A; Freilich D; Gommans DHF; Gracia-Ramos AE; Murray TA; Pelorosso F; Poulter NR; Puskarich MA; Rizas KD; Rothlin R; Schlaich MP; Schreinlecher M; Steckelings UM; Sharma A; Stergiou GS; Tignanelli CJ; Tomaszewski M; Unger T; van Kimmenade RRJ; Wainford RD; Williams B; Rodgers A; Schutte AE;
    J Am Heart Assoc; 2022 Sep; 11(17):e026143. PubMed ID: 36000426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between early worsening of kidney function and poor outcomes in patients treated with renin angiotensin system inhibitors: A meta-analysis.
    Yuan S; Liu Y; He W; Jin J; Liu L; He Q
    Nephrology (Carlton); 2021 Oct; 26(10):772-781. PubMed ID: 34165226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials.
    Bangalore S; Fakheri R; Wandel S; Toklu B; Wandel J; Messerli FH
    BMJ; 2017 Jan; 356():j4. PubMed ID: 28104622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of continuing the use of renin-angiotensin system inhibitors on mortality in patients hospitalized for coronavirus disease 2019: a systematic review, meta-analysis, and meta-regression analysis.
    Liu Q; Fu W; Zhu CJ; Ding ZH; Dong BB; Sun BQ; Chen RC
    BMC Infect Dis; 2023 Jan; 23(1):53. PubMed ID: 36694122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of renin-angiotensin system blockers on outcomes from COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Lee MMY; Kondo T; Campbell RT; Petrie MC; Sattar N; Solomon SD; Vaduganathan M; Jhund PS; McMurray JJV
    Eur Heart J Cardiovasc Pharmacother; 2024 Jan; 10(1):68-80. PubMed ID: 37740450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial).
    Legrand M; Futier E; Leone M; Deniau B; Mebazaa A; Plaud B; Coriat P; Rossignol P; Vicaut E; Gayat E;
    Trials; 2019 Mar; 20(1):160. PubMed ID: 30836981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-angiotensin system modulation and outcomes in patients hospitalized for interstitial SARS-CoV2 pneumonia: a cohort study.
    Landolfo M; Maino A; Di Salvo E; Fiorini G; Peterlana D; Borghi C
    Intern Emerg Med; 2022 Aug; 17(5):1335-1341. PubMed ID: 35064437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective meta-analysis protocol on randomised trials of renin-angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension.
    Gnanenthiran SR; Borghi C; Burger D; Charchar F; Poulter NR; Schlaich MP; Steckelings UM; Stergiou G; Tomaszewski M; Unger T; Wainford RD; Williams B; Rodgers A; Schutte AE
    BMJ Open; 2021 Feb; 11(2):e043625. PubMed ID: 33593784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers for hypertension.
    Wiysonge CS; Bradley HA; Volmink J; Mayosi BM; Opie LH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002003. PubMed ID: 28107561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Renin-Angiotensin System Inhibitors on Mortality and Disease Severity of COVID-19 Patients: A Meta-analysis of Randomized Controlled Trials.
    Yin J; Wang C; Song X; Li X; Miao M
    Am J Hypertens; 2022 May; 35(5):462-469. PubMed ID: 35512430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults.
    Zou Z; Yuan HB; Yang B; Xu F; Chen XY; Liu GJ; Shi XY
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD009210. PubMed ID: 26816003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
    Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
    JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.
    Cohen JB; Hanff TC; William P; Sweitzer N; Rosado-Santander NR; Medina C; Rodriguez-Mori JE; Renna N; Chang TI; Corrales-Medina V; Andrade-Villanueva JF; Barbagelata A; Cristodulo-Cortez R; Díaz-Cucho OA; Spaak J; Alfonso CE; Valdivia-Vega R; Villavicencio-Carranza M; Ayala-García RJ; Castro-Callirgos CA; González-Hernández LA; Bernales-Salas EF; Coacalla-Guerra JC; Salinas-Herrera CD; Nicolosi L; Basconcel M; Byrd JB; Sharkoski T; Bendezú-Huasasquiche LE; Chittams J; Edmonston DL; Vasquez CR; Chirinos JA
    Lancet Respir Med; 2021 Mar; 9(3):275-284. PubMed ID: 33422263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers for COVID-19: A living systematic review of randomized clinical trials.
    Meza N; Pérez-Bracchiglione J; Pérez I; Carvajal C; Ortiz-Muñoz L; Olguín P; Rada G; Madrid E;
    Medwave; 2021 Mar; 21(2):e8105. PubMed ID: 33830976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation vs Discontinuation of Renin-Angiotensin System Inhibitors Before Major Noncardiac Surgery: The Stop-or-Not Randomized Clinical Trial.
    Legrand M; Falcone J; Cholley B; Charbonneau H; Delaporte A; Lemoine A; Garot M; Joosten A; Meistelman C; Cheron-Leroy D; Rives JP; Pastene B; Dewitte A; Sigaut S; Danguy des Deserts M; Truc C; Boisson M; Lasocki S; Cuvillon P; Schiff U; Jaber S; Le Guen M; Caillard A; Bar S; Pereira de Souza Neto E; Colas V; Dimache F; Girardot T; Jozefowicz E; Viquesnel S; Berthier F; Vicaut E; Gayat E;
    JAMA; 2024 Sep; 332(12):970-978. PubMed ID: 39212270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of renin-angiotensin-aldosterone system inhibitors on continuous and binary kidney outcomes in subgroups of patients with diabetes: a meta-analysis of randomized clinical trials.
    Alsalemi N; Sadowski CA; Elftouh N; Louis M; Kilpatrick K; Houle SKD; Lafrance JP
    BMC Nephrol; 2022 Apr; 23(1):161. PubMed ID: 35484505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme inhibitors reduce mortality compared to angiotensin receptor blockers: Systematic review and meta-analysis.
    Salvador GL; Marmentini VM; Cosmo WR; Junior EL
    Eur J Prev Cardiol; 2017 Dec; 24(18):1914-1924. PubMed ID: 28862020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Combined Renin-Angiotensin System Inhibitors and Diuretic Treatment In Patients Hospitalized with COVID-19.
    Palazzuoli A; Tecson KM; Vicenzi M; D'Ascenzo F; De Ferrari GM; Monticone S; Secco GG; Tavazzi G; Forleo G; Severino P; Fedele F; De Rosa F; McCullough PA
    Am J Cardiol; 2022 Mar; 167():133-138. PubMed ID: 35027137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.